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Abstract: Low-fat diets and energy restriction are recommended to prevent obesity and to induce
weight loss, but high-protein diets are popular alternatives. However, the importance of the protein
source in obesity prevention and weight loss is unclear. The aim of this study was to investigate
the ability of different animal protein sources to prevent or reverse obesity by using lean or obese
C57BL/6J mice fed high-fat/high-protein or low-fat diets with casein, cod or pork as protein sources.
Only the high-fat/high-protein casein-based diet completely prevented obesity development when
fed to lean mice. In obese mice, ad libitum intake of a casein-based high-fat/high-protein diet modestly
reduced body mass, whereas a pork-based high-fat/high-protein diet aggravated the obese state and
reduced lean body mass. Caloric restriction of obese mice fed high-fat/high-protein diets reduced
body weight and fat mass and improved glucose tolerance and insulin sensitivity, irrespective of
the protein source. Finally, in obese mice, ad libitum intake of a low-fat diet stabilized body weight,
reduced fat mass and increased lean body mass, with the highest loss of fat mass found in mice fed
the casein-based diet. Combined with caloric restriction, the casein-based low-fat diet resulted in the
highest loss of fat mass. Overall, the dietary protein source has greater impact in obesity prevention
than obesity reversal.
Keywords: obesity; diet; dietary protein source; macronutrient composition; weight loss; glucose
tolerance; insulin sensitivity; mice
1. Introduction
Weight loss is the main target in order to reduce the risk for diabetes in humans [1]. Conventional
weight loss strategies typically recommend overweight and obese persons to reduce fat intake in order
to reduce the energy intake by 500–750 calories [2]. However, high-protein (HP) diets are becoming
a popular alternative to energy restriction for body weight maintenance and weight loss in humans.
In addition to an increased satiating effect, HP diets are reported to increase energy expenditure [3–5].
However, the long term health effects of HP diets, in particular when combined with high-fat (HF)
intake, remain controversial [6], and unless the dietary intervention is combined with energy restriction,
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the long term efficiency of HP diets to induce weight loss in humans is inconclusive, as demonstrated
in systematic reviews and meta-analyses [7–9].
Whereas human trials mainly have examined the ability of HP diets to induce weight loss in obese
subjects, the effects of HP diets in rodents have primarily been investigated in relation to the prevention
of obesity development. A number of animal trials have reported that HF/HP diets efficiently attenuate
and even prevent the development of obesity [10–19], but the ability of HF/HP diets to reverse obesity
in rodents is far less clear. An important issue regarding HF/HP diets relates to reports indicating
that the dietary fat content, rather than the obese state, may be a key determinant for dysregulated
glucose homeostasis [20–22]. Whereas it is well documented that weight loss is induced by caloric
restriction [23], low-fat (LF) diets [24] and exercise [25] also lead to improved glucose homeostasis and
insulin sensitivity in mice. Still, it is not yet known if HF/HP diets ameliorate or worsen dysregulated
glucose metabolism in already obese mice.
In the majority of the animal studies demonstrating that a HP content can prevent obesity, casein
or whey is used as the sole protein source [12–19]. However, both casein and whey appear to have
anti-obesogenic properties and may not be representative. We have previously observed that mice fed
HF/HP diets based on casein remain lean, but if the protein source is chicken, pork or beef, weight gain
is greatly increased, reflecting an increase in fat mass [26]. An association between maintenance of
classical brown morphology in the interscapular brown adipose tissue and obesity prevention has been
observed, but a direct causal link between these findings has not yet been demonstrated. Furthermore,
it is not known whether casein is able to reverse the white phenotype of the interscapular fat depot in
obese mice.
Although a number of human trials have examined the ability of HP diets to induce weight loss in
obese subjects [7–9], the importance of the protein source remains unclear. In several of these trials, the
dietary intervention was combined with energy restriction, and differences in design made it difficult
to arrive at solid conclusions [3]. Nonetheless, when consumed at regular levels in habitual diets,
different protein sources appear to have different obesogenic properties in humans. Epidemiological
and prospective studies suggest that while a high intake of meat from terrestrial sources, in particular
red meat, is associated with weight gain, intake of marine, dairy and vegetarian protein sources is
associated with protection against becoming overweight [27,28]. Hence, it remains an open question
whether protein sources are of more importance in preventing weight gain than in diets used to achieve
weight loss, in particular if energy is restricted.
The present global obesity epidemic emphasizes the need for effective weight loss strategies in
addition to effective methods for weight gain prevention. Given the popularity of HP diets, we here
aimed to investigate if HP diets that can attenuate obesity development are able to reverse obesity in
mice, or if concomitant energy restriction is a prerequisite for weight loss. Furthermore, we aimed
to systematically investigate the impact of different animal protein sources on weight loss, glucose
tolerance and insulin sensitivity when combined with different macronutrient compositions and
energy access. The use of mice as a model allows for a systematic investigation of the importance
of the protein source in putative weight loss induced by dietary interventions and the evaluation of
the possible detrimental or beneficial effects of the diets on glucose tolerance and insulin sensitivity.
We demonstrate that the dietary protein source is of higher importance in the development of obesity
when fed to lean mice than when fed to already obese mice ad libitum. Unless accompanied with
energy restriction, HF/HP diets generally do not reverse obesity and dysregulated glucose homeostasis
efficiently. Finally, we demonstrate that the protein source is of less importance when the dietary
interventions are combined with energy restriction, and the regulation of glucose homeostasis appears
to follow the degree of obesity rather than the dietary fat content.
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2. Materials and Methods
2.1. Ethical Statement
All animal experiments were approved by the Norwegian Animal Research Authority (FOTS
id.nr 5358). Animal handling and experimental protocols were performed in accordance with the
guidelines of the national authorities and the European Convention for the Protection of Animals
used for scientific purposes (regulation on the use of animals in research, Ministry of Agriculture and
Food, 1 July 2015; according to Directive 2010/63/EU of the European Parliament and of the Council of
22 September 2010). No adverse effects were observed during the experiments.
2.2. Animal Experiments
In all animal experiments, C57BL/6J male mice, 8 weeks old, obtained from Taconic Europe (Ejby,
Denmark) were used. Body weight was recorded every week and fresh water was provided twice
a week. Body composition analyses were, in addition, measured at the start and at the designated
time-points for each animal experiment, as described in Section 2.4. All mice fed ad libitum were given
new feed three times each week, and feed leftovers were recorded. The mice fed with 30% energy
restriction were fed each day in that period to avoid prolonged fasting periods between feeding, and
feed leftovers were recorded. All animals were housed in a thermoneutral environment (29 ± 1 ◦C)
with 50% relative humidity and a 12-h light/dark cycle. The mice were sacrificed during 4% isoflurane
anesthesia (Isoba vet, Schering-Plough A/S, Farum, Denmark) by cardiac puncture and adipose tissues
were dissected out, snap-frozen in liquid nitrogen and stored at −80 ◦C.
2.2.1. First Animal Experiment
The first animal experiment was performed using 45 lean male mice, 8 weeks old. After one week
of acclimatization, body mass composition was determined and mice were divided into groups with
similar body weight (25 ± 0.7 g), fat mass (2.5 ± 0.2 g) and lean mass (18.5 ± 0.6 g). The mice were fed
the experimental diets (Table 1) ad libitum, including a LF diet, a high-fat/high-sucrose (HF/HS) diet
and HF/HP diets based on either casein, cod or pork for 12 weeks (n = 9). All animals were subjected
to an oral glucose tolerance test (OGTT) and an insulin tolerance test (ITT) after 10 and 11 weeks,
respectively, as further described in Section 2.5. In week 6, total feces was collected during 7 days from
all the individual cages, weighed and analyzed for total nitrogen and total fat content as previously
described [29]. Apparent digestibility of nitrogen and fat were determined using the total fat and
nitrogen content in the collected feces, in addition to the total dietary fat and nitrogen intake during
the 7 days of feces collection.
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Table 1. Dietary composition of the HF/HS 1 diet and the HF/HP 2 diets.
Component (g/kg) HF/HS HF/HP Casein HF/HP Cod HF/HP Pork LF 3 Casein LF Cod LF Pork
Casein # 69 416 207
Cod # 67 431 215
Pork # 73 461 217
Potato starch (dextrin) 11 21 9,31 0 531 524 530
Sucrose 439 214 214 214 92 92 92
Corn oil 242 248 245 224 69 69 61
Cellulose 50 50 50 50 50 50 50
t-Butylhydroquinone 0.014 0.014 0.014 0.014 0.014 0.014 0.014
Mineral mix: SDS, AIN93Gminmix 35 35 35 35 35 35 35
Vitamin mix: SDS, AIN93VX
NCR95compliant 10 10 10 10 10 10 10
Choline bitartrate 2.5 2.5 2.5 2.5 2.5 2.5 2.5
L-Cystine 3 3 3 3 3 3 3
Total 1000 1000 1000 1000 1000 1000 1000
1 High-fat/high-sucrose (HF/HS), 2 high-fat/high-protein (HF/HP), 3 low-fat (LF) diets # added to the diets in amounts equal to 200 g crude protein/kg (33 E%) for the LF diets and 400 g
crude protein/kg (16 E%) for the HF/HP diet. SDS—Special Diets Services.
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2.2.2. Second Animal Experiment
The second animal experiment was performed using 40 already obese male mice. In order to
achieve obesity (mean body weight: 41.1 ± 0.5 g, mean fat mass: 17.0 ± 0.3 g), 8 week old mice were fed
a HF/HS diet ad libitum (Table 1) for 8 weeks. Body composition was determined in all the obese mice
and used to divide the mice into groups with similar body weight, fat mass and lean mass. The obese
mice received the different experimental diets ad libitum, including HF/HP diets based on casein, cod
or pork, or continued receiving a HF/HS diet for 6 weeks. After 4 and 5 weeks on the experimental
diets, all animals were subjected to an ITT and an OGTT as further described in Section 2.5.
2.2.3. Third Animal Experiment
The third animal experiment was performed using 52 already obese male mice. In order to achieve
obesity (mean body weight: 43.1 ± 0.5 g, mean fat mass: 17.0 ± 0.2 g), 8 week old mice were fed a
HF/HS (Table 1) ad libitum for 9 weeks. Body composition was determined and used to divide the
obese mice into groups with similar body weight, fat mass and lean mass. The obese mice received the
different experimental diets with a 30% energy restriction, including HF/HP diets based on casein, cod
or pork, or continued on a HF/HS diet ad libitum for 6 weeks. Energy restricted mice received 1.75 g of
feed every day. After 4 and 5 weeks on the experimental diets, all animals were subjected to an ITT
and an OGTT as further described in Section 2.5.
2.2.4. Fourth Animal Experiment
The fourth animal experiment was performed using 40 already obese male mice. In order to
achieve obesity (mean body weight: 41.8 ± 0.7 g, mean fat mass: 17.9 ± 0.6 g), 8 week old mice were
first fed a very high-fat (VHF) diet ad libitum (Ssniff EF R/M acc D12492, Soest, Germany) for 18 weeks.
Body composition was determined and used to divide the obese mice into groups with similar body
weight, fat mass and lean mass. The obese mice received the different experimental diets ad libitum,
including LF diets based on casein, cod or pork (Table 1), or continued on a VHF diet ad libitum for
6 weeks. After 4 and 5 weeks on the experimental diets, all animals were subjected to an ITT and an
OGTT as further described in Section 2.5.
2.2.5. Fifth Animal Experiment
The fifth animal experiment was performed using 52 already obese male mice. In order to achieve
obesity (mean body weight: 42.0 ± 0.5 g, mean fat mass: 18.0 ± 0.5 g), 8 week old mice were first fed
a VHF diet ad libitum (Ssniff EF R/M acc D12492, Soest, Germany) for 13 weeks. Body composition
was determined and used to divide the obese mice into groups with similar body weight, fat mass
and lean mass. The obese mice received the different experimental diets with a 30% energy restriction,
including LF diets based on casein, cod or pork (Table 1), or continued on a VHF diet ad libitum for
6 weeks. Energy restricted mice received 2.0 g feed every day. After 4 and 5 weeks on the experimental
diets, all animals were subjected to an ITT and an OGTT as further described in Section 2.5.
2.3. Animal Diets
All HF/HP and LF diets based on different protein sources (Table 1) were prepared by the use
of either casein powder (C8654 SIGMA, Merck, Darmstadt, Germany), fillets from frozen cod (Lerøy
Alfheim AS, Bergen, Norway) or fresh pork sirloins (H. Bragstad A/S, Bergen, Norway). The cod fillets
and pork sirloins were heat treated (70 ◦C), freeze dried and powdered before being added to the
diets in amounts equal to 200 g crude protein/kg for the LF diets and 400 g crude protein/kg for the
HF/HP diets (Table 1), calculated from measurements of nitrogen content in the powders as described
previously [30]. In addition, the endogenous total fat content in the protein powders was measured as
described previously [29] and the diets were adjusted with corn oil to achieve an equal amount of total
fat in the diets.
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2.4. Body Composition Measurements
Whole-body composition, fat mass, lean mass and free water were measured by noninvasive
scanning that uses a time-domain nuclear magnetic resonance system (Bruker Minispec LF50 Body
Composition Analyzer mq 7.5 (Bruker Optic GmbH, Ettlingen, Germany)) as previously described [31].
2.5. Glucose- and Insulin Tolerance Tests
An OGTT and ITT were performed in all the animals at designated time-points during the feeding
trials. The OGTT was performed in fasted (6 h) animals which received 3 mg glucose per g lean body
mass by oral gavage. The ITT was performed in fed animals receiving an intraperitoneal injection of 1
U insulin per kg lean body mass. In both tests, glucose levels were measured in blood collected from
the tail vein at the indicated time points using a glucometer (Ascensia Contour, Bayer, Norway).
2.6. Histology and Immunohistochemistry
Parts of the adipose tissue, inguinal white adipose tissue (iWAT) and interscapular brown adipose
tissue (iBAT), were excised and fixated overnight in 4% formaldehyde dissolved in 0.1 M phosphate
buffer at 4 ◦C. After fixation, the tissues were dehydrated, cleared in xylene and embedded in paraffin.
Sections (5 µm) of the paraffin embedded tissues were stained with hematoxylin and eosin (H&E) for
further morphological evaluations using a Nikon Eclipse Ti microscope (Nikon Instruments Inc., New
York, USA) and micrographs captured by a Nikon DS-Fi3 camera (Nikon Instruments Inc., New York,
USA). Immunohistochemical detection of uncoupling protein 1 (UCP1) in iBAT was performed as
described previously [20] and quantified using Image J, Fiji [32].
2.7. Quantitative Reverse Transcriptase PCR (qRT-PCR)
Total RNA was purified from iWAT and iBAT and used to further synthesize complementary
DNA by reverse transcription PCR, and real time PCR was performed, as previously described [33].
Primers specific for the designated genes were designed using Primer Express 2.0 (Applied Biosystems)
and the sequences are listed in Table S1. The relative expression levels of target genes were normalized
to the gene expression of TATA box binding protein (Tbp).
2.8. Statistical Analysis
The data presented in graphs are mean ± standard error of the mean (SEM). Homogeneity of
variances was tested using the Brown–Forsythe test and the normality of distribution was tested
using the D’Agostine–Pearson omnibus normality test. No significant differences were detected.
An ANOVA with an uncorrected Fisher’s Least Significant Difference (LSD) for multiple comparisons
was performed to compare the experimental groups. Different letters denote statistical differences
(P < 0.05). All statistical tests and calculations of area under and over curves were performed using
GraphPad Prism 7 (GraphPad Software, Inc, San Diego, USA).
3. Results
3.1. The Protein Source Determines the Impact of High Protein Diets on the Development of Obesity, Glucose
Tolerance and Insulin Sensitivity in Lean Mice
First, we aimed to evaluate glucose tolerance and insulin sensitivity, and to verify the different
obesogenic potential of casein, cod and pork as protein sources in HF/HP diets. Hence, we fed lean male
mice HF/HP diets based on proteins from either casein, cod or pork (Table 1) for 12 weeks. Compared
with casein-fed mice, pork-fed mice had a lower lean mass, larger adipocyte size, reduced glucose
tolerance and insulin sensitivity (Figure 1a–d and Figure S1a,b), while cod-fed mice had a higher lean
mass and increased insulin sensitivity compared with pork-fed mice (Figure 1c,d,g). As previously
demonstrated [26], the HF/HP diet with pork was highly obesogenic (Figure 1e,f). Mice fed the HF/HP
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diet containing casein remained as lean as control mice fed a LF reference diet, whereas body weight
gain and fat mass of mice fed the cod-containing diet were higher compared with casein and lower in
comparison with chicken. The feed intake was not different (Figure S2a), and feed efficiency reflected
the weight gain (Figure 1h). As fat digestibility was higher only in mice fed casein, and nitrogen
digestibility was not affected by the protein source (Figure S2b,c); these parameters cannot explain the
differences in obesity development between the protein sources.
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Figure 1. (a) Blood glucose levels during the oral glucose tolerance test (OGTT) performed in week
10 of feeding ad libitum high-fat/high-protein (HF/HP) diets based on different protein sources to lean
mice, in addition to one group fed a lo -fat (LF) diet and one fed a high-fat/high-sucrose (HF/HS)
diet. (b) Area under the curve ( r the OG T. (c) Glucos levels during the su in tolerance
test (ITT) in week 11 and (d) the dec tal area over the curve (AOC . (e) Body weight gain after
10 weeks, (f) fat mass and (g) lean ss i eek 9 and (h) feed efficiency after 10 weeks. Data are
presented as mean ± standard error of the mean (SEM) (n = 8–9) and different letters denote significant
differences (P < 0.05) by one-way ANOVA using uncorrected Fisher’s Least Significant Difference (LSD)
multiple comparison.
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In agreement with earlier studies [26], the obese phenotype of the pork-fed mice was accompanied
with a profound “whitening” of the classical iBAT (Figure S1d), whereas mice fed casein maintained a
classic brown adipocyte morphology with multilocular lipid droplets and increased protein expression
of UCP1 (Figure S1e). Hence, the ability of casein-based HF/HP diets to enable the maintenance of a
brown phenotype in iBAT and prevent obesity was verified. Furthermore, mice fed the casein-based
diet had a higher expression of Ucp1, deiodinase iodothyronine type II (Dio2) and peroxisome
proliferator-activated receptor-g coactivator 1a (Ppargc1a) in iWAT compared with mice fed pork
(Figure S1c), suggesting an increased browning of the white adipose tissue. In cod-fed mice, expression
levels of brown adipose tissue (BAT) marker genes in iWAT, as well as UCP1 protein expression
levels in iBAT were intermediate compared with the levels of casein- and pork-fed mice, but not
significantly different from either. Thus, the profound difference in adiposity between mice fed HF/HP
diets with casein or pork as protein sources was accompanied by differences in iBAT morphology,
glucose tolerance and insulin sensitivity.
3.2. The Impact of Protein Source in Obese Mice Fed High Protein Diets
3.2.1. High Protein Diets Fed Ad Libitum to Obese Mice
In order to investigate the ability of HP diets to reverse obesity, obese mice (body weight:
41.1 ± 0.5 g, fat mass: 17.0 ± 0.3 g, lean mass: 18.1 ± 0.2 g) were fed HF/HP diets based on proteins from
either casein, cod or pork (Table 1) for 6 weeks ad libitum. Although a casein-based HF/HP diet is able to
prevent the development of obesity, feeding obese mice this diet led to only a modest decrease in body
weight (0.93 g) and fat mass (1.15 g). Whilst an ad libitum intake of a HF/HP diet based on pork further
increased body and fat mass in the obese mice (Figure 2a,b), ad libitum intake of a HF/HP diet based on
cod prevented further weight and fat mass gain. Thus, although feeding obese mice HF/HP diets for 6
weeks did not reverse obesity, a differential impact of the protein source on adiposity was still evident.
Histological examination and immunostaining of UCP1 in iBAT revealed a white phenotype in samples
from all groups, including samples collected from obese mice prior to the dietary intervention (Figure
S3a,b). In line with this, no differences in the expression of Ucp1, Dio2 and Ppargc1a in iBAT were
evident (Figure S4a). Hence, although a casein-based HF/HP diet appears to enable maintenance of a
brown phenotype in iBAT, this diet cannot reverse whitening of the tissue. However, the expression
of leptin, a gene normally expressed at high levels in white adipocytes, was significantly higher in
the brown adipose tissue of pork-fed mice. The adipocytes from the iWAT tended to be enlarged in
mice fed HF/HP diets based on pork (P = 0.06) compared with cod (Figure S3c,d). In line with this,
expression of genes related to browning (Ucp1, Dio2, Ppargc1a) was low in mice fed the HF/HP diet
based on pork (Figure S4b). Increased expression of these marker genes in iWAT was evident for all the
mice with a high casein intake, both after feeding lean and obese mice ad libitum, and in comparison
with pork and/or cod (Figures S1c and S4b).
A reduction in lean mass was observed after 6 weeks of intervention in mice fed the pork-based
diet (Figure 2c). The reduction in lean mass was also significantly higher in mice fed pork, compared
with mice fed either casein or cod, which preserved the lean mass throughout the intervention. Feed
efficiency mirrored the change in body weight and fat mass, demonstrating a greater feed efficiency in
mice fed pork compared with mice fed either casein or cod (Figure 2d).
Following the change in body weight, pork-fed mice had the highest area under the curve for
the OGTT and were less sensitive to insulin compared with casein- or cod-fed mice (Figure 2e–h).
In comparison to their state prior to the intervention, all mice fed the HF/HP diets demonstrated an
improvement in glucose tolerance according to the area under the curve for the OGTT, whereas only
mice fed HF/HP diets based on casein had an improved insulin sensitivity according to the area over
the curve for the ITT.
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Figure 2. (a) Body weight change, (b) fat mass change and (c) lean mass change after 6 weeks of feeding
high-fat/high-protein (HF/HP) diets based on different protein sources ad libitum to already obese mice,
in addition to one group fed the obesogenic high-fat/high-sucrose (HF/HS) diet. (d) Feed efficiency
(g/MJ) from 6 weeks of HF/HP feeding. (e) Blood glucose levels during the oral glucose tolerance test
(OGTT) performed in week 4 and (f) area under the curve (AUC) for the OGTT. (g) Blood glucose levels
during the insulin tolerance test (ITT) in week 5 and (h) area over the curve (AOC) for the ITT. Data are
presented as mean ± SEM (n = 9–12) and different letters denote significant differences (P < 0.05) by
one-way ANOVA using uncorrected Fisher’s LSD multiple comparison.
3.2.2. High Protein Diets Combined with Calorie Restriction
Next, we investigat d if the prot in sources influenced th ability of HF/HP diets to revers obesity
during caloric restriction. For this purpose, obese mic (body weight: 43.1 ± 0.5 g, fat mass: 17.0 ± 0.2 g,
lean mass: 19.8 ± 0.2 g) were fed the same HF/HP diets combine with 30% calorie restricti n for
6 weeks. Body mass, fat mass, lean mass and feed efficiency were reduced in all mice fed HF/HP
diets with calorie restriction with no further differences being evident between the different protein
sources (Figure 3a–d). Morphological examination of iBAT in mice fed either of the diets revealed a
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brown phenotype, whereas the expression levels of classical brown adipocyte marker genes were not
influenced by the dietary protein source in iBAT (Figures S4a and S5b). The expression levels of genes
related to browning (Ucp1, Dio2, Ppargc1a) were not higher in iWAT from casein-fed mice (Figure S4b).
In fact, during caloric restriction, expression of these genes was slightly elevated in cod-fed mice when
compared with mice fed casein.Nutrients 2019, 11, x FOR PEER REVIEW  10 of 22 
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3.3. The Impact of Protein Source on Weight Loss in Obese Mice Given Low Fat Diets 
Figure 3. (a) Body weight change, (b) fat mass change and (c) lean mass change after 6 weeks of
feeding high-fat/high-protein (HF/HP) diets based on different protein sources with 30 per cent calorie
restriction (CR) to already obese mice, in addition to one group fed the obesogenic high-fat/high-sucrose
(HF/HS) diet ad libitum. (d) Feed efficiency (g/MJ) from 6 weeks of HF/HP feeding. (e) Blood glucose
levels during the oral glucose tolerance test (OGTT) performed in week 4 and (f) area under the curve
(AUC) for the OGTT. (g) Blood glucose levels during the insulin tolerance test (ITT) in week 5 and
(h) area over the curve (AOC) for the ITT. Data are presented as mean ± SEM (n = 9–13) and different
letters denote significa t differences (P < 0.05) by on -way ANOVA using uncorrected Fisher’s LSD
multiple comparison.
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Consistent with body mass and fat mass loss, all the HF/HP diets induced an improvement in
glucose tolerance and insulin sensitivity in the obese mice compared with before the diet started and
to the mice that continued receiving the obesogenic reference diet (Figure 3e–h). However, there were
no differences in glucose tolerance or insulin sensitivity between mice fed the different protein sources
with calorie restriction. Thus, the protein source of the high-fat/high-protein (HF/HP) diets appeared
to be of importance in prevention of weight gain when given ad libitum to lean and obese mice, but this
was absent in combination with caloric restriction.
3.3. The Impact of Protein Source on Weight Loss in Obese Mice Given Low Fat Diets
To evaluate the importance of the protein source during ad libitum feeding vs. caloric restriction in
weight loss diets with regular protein amount, LF diets based on casein, cod or pork were prepared.
First, obese mice (body weight: 41.8 ± 0.7 g, fat mass: 17.9 ± 0.6 g, lean mass: 18.8 ± 0.1 g), were
fed the LF diets ad libitum for 6 weeks. As a reference, one group of mice was continuously fed the
obesogenic VHF diet. The body mass of all mice fed LF diets (Table 1) ad libitum was stabilized or
modestly decreased throughout the 6 week intervention period, with a reduction in body weight of
mice fed casein compared with cod or pork (Figure 4a). This pattern was also reflected in their feed
efficiency (Figure 4d). Despite a stable body weight, fat mass was reduced in all LF-fed mice, with the
highest fat mass loss found in mice fed casein (Figure 4b). An increase in lean mass was evident in all
mice fed LF diets, with a higher increase in the mice fed LF diets based on cod compared with pork
(Figure 4c). Hence, the protein source was a decisive factor for changes in body composition of mice
fed LF diets ad libitum.
Next, we investigated whether differences between the protein sources in LF diets were revoked
in combination with caloric restriction. Hence, a new set of obese mice (body weight: 42.0 ± 0.5 g, fat
mass: 18.0 ± 0.5 g, lean mass: 18.9 ± 0.1 g) were fed LF diets with casein, cod or pork combined with
30% calorie restriction for 6 weeks. As expected, body mass and fat mass loss were observed in all
groups (Figure 4e,f). In contrast to the combination of HF/HP diets with energy restriction, mice fed a
casein-based LF diet with calorie restriction demonstrated a higher body weight loss compared with
mice fed cod or pork. This pattern was also reflected in their feed efficiency (Figure 4h). Reduction in
body mass was mainly caused by fat mass loss, with higher fat mass loss in mice fed casein compared
with cod. Overall, an increase in lean mass was evident with the LF intake, despite calorie restriction,
with a higher lean mass gain in mice fed cod compared with casein or pork (Figure 4g).
No distinct expression pattern was observed for the marker genes related to browning measured
in iWAT of LF fed mice ad libitum or with calorie restriction (Figure S6a). Mice fed a casein-based
LF diet demonstrated an upregulated Ucp1 expression in iBAT compared with mice fed cod or pork,
independent of feed access. In addition, the expression of glycerol kinase (Gk) was upregulated
in iBAT of casein-fed mice compared with mice fed cod and pork diets ad libitum or with calorie
restriction (Figure S6b), which has been demonstrated to play an important role for the thermogenic
function/capacity of brown adipocytes [34].
Despite fat mass loss and lean mass increase in all LF-fed ad libitum groups, glucose tolerance was
not improved and insulin sensitivity was improved only in casein-fed mice (Figure 5a–d). Consistent
with the differences in fat mass, all energy restricted LF-fed mice had improved glucose tolerance
and insulin sensitivity (Figure S5e–h). In both ad libitum and energy restricted groups, the glucose
tolerance tests demonstrated that mice fed LF diets based on casein had improved glucose tolerance
compared with mice fed cod or pork. This was also in accordance with greater insulin-stimulated
glucose responses in mice fed a LF diet ad libitum with casein compared with cod, although not
compared with pork. Hence, the protein source was also of importance for glucose metabolism during
LF intake. However, the impact of the protein source on glucose metabolism was more pronounced
when mice were fed ad libitum than under energy restriction.
Nutrients 2019, 11, 1153 12 of 19
Nutrients 2019, 11, x FOR PEER REVIEW  12 of 22 
 
 
Figure 4. (a) Body weight change, (b) fat mass change and (c) lean mass change after 6 weeks of 
feeding low-fat (LF) diets based on different protein sources ad libitum to already obese mice, in 
addition to one group fed the obesogenic very high-fat (VHF) diet ad libitum. (d) Feed efficiency (g/MJ) 
from 6 weeks of LF feeding. (e) Body weight change, (f) fat mass change and (g) lean mass change 
after 6 weeks of feeding LF diets based on different protein sources with 30 per cent calorie restriction 
(CR) to already obese mice, in addition to one group fed the obesogenic VHF diet ad libitum. (h) Feed 
efficiency (g/MJ) from 6 weeks of LF feeding. Data are presented as mean ± SEM (n = 9–13) and 
different letters denote significant differences (P < 0.05) by one-way ANOVA using uncorrected 
Fisher’s LSD multiple comparison. 
Figure 4. (a) Body weight change, (b) fat mass change and (c) lean mass change after 6 weeks of feeding
low-fat (LF) diets based on different protein sources ad libitum to already obese mice, in addition to
one group fed the obesogenic very high-fat (VHF) diet ad libitum. (d) Feed efficiency (g/MJ) from
6 weeks of LF feeding. (e) Body weight change, (f) fat mass change and (g) lean mass change after
6 weeks of feeding LF diets based on different protein sources with 30 per cent calorie restriction (CR)
to already obese mice, in addition to one group fed the obesogenic VHF diet ad libitum. (h) Feed
efficiency (g/MJ) from 6 weeks of LF feeding. Data are presented as mean ± SEM (n = 9–13) and different
letters denote significant differences (P < 0.05) by one-way ANOVA using uncorrected Fisher’s LSD
multiple comparison.
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4. Discussion 
Figure 5. (a) Blood glucose levels during the oral glucose tolerance test (OGTT) performed in week
4 of feeding low-fat (LF) diets based on different protein sources ad libitum to already obese mice, in
addition to one group fed the obesogenic very high-fat (VHF) diet ad libitum. (b) Area under the curve
(AUC) for the OGTT. (c) Glucose levels during the insulin tolerance test (ITT) in week 5 and (d) the
decremental area over the curve (AOC). (e) Blood glucose levels during the OGTT performed in week 4
feeding LF diets based on different protein sources with 30 percent calorie restriction (CR) to already
obese mice, in addition to one group fed the obesogenic VHF diet ad libitum. (f) AUC for the OGTT.
(g) Glucose levels during the ITT in week 5 and (h) the decremental AOC. Data are presented as mean
± SEM (n = 9–13) and different letters denote significant differences (P < 0.05) by one-way ANOVA
using uncorrected Fisher’s LSD multiple comparison.
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4. Discussion
Using systematically designed mouse trials, we here demonstrated that the different dietary animal
protein sources are of more importance in preventing weight gain than in diets used to achieve weight
loss, particularly if energy is restricted. In line with earlier observations [26], different protein sources
demonstrated profound differences in their ability to modulate obesity development in lean mice fed
HF/HP diets. Whereas mice fed the casein-based diet remained lean, mice fed pork developed obesity
and mice fed cod were in-between. Similarly, in experiments using obesogenic diets with regular
protein amounts, it was demonstrated that protein from vegetable sources, milk protein and proteins
from seafood are less obesogenic than proteins from terrestrial animals [29,35–37]. These results are in
line with human prospective studies indicating that an increased intake of protein from vegetarian
sources, dairy and seafood protect against obesity, whereas a high intake of meat, in particular red
meat, is associated with higher weight gain [27,28,38]. Of note, changes in most protein foods were
inversely correlated with changes in carbohydrate at the baseline, and replacing protein-rich food for
carbohydrate-rich foods was essential for long-term weight maintenance [28].
An important finding in this study is that, unless combined with energy restriction, HF/HP diets
do not reverse obesity. When fed ad libitum, the obese state is modestly reduced when casein is used as
the protein source and aggravated when pork is used. Meta-analyses of HP diets on weight loss in
humans report modest or no effect [7–9]. In these human trials, different protein sources were used,
and several interventions combined HP diets with energy restriction. Hence, it is tempting to speculate
if the lack of consistency in results from human trials may relate to different designs of the human
trials with respect to energy restriction and/or the possible impact of different protein sources when the
diets are given ad libitum.
Casein is commonly used as the protein source in commercially available rodent feed. We here
confirm the earlier observation [26] that casein is not a representative protein source. When given
ad libitum, only the casein-based HF/HP diet was able to reduce body mass and fat mass in obese
mice, whereas the pork-based diet aggravated the obese state. Furthermore, feeding obese mice
a casein-based LF diet reduced the fat mass significantly more than cod- and pork-based LF diets.
A recent evaluation from meta-analyses of observational studies and randomized controlled trials
concluded that the intake of milk and dairy products can also improve body composition and facilitate
weight loss in humans [39]. The anti-obesogenic effect of casein and whey may relate to their relatively
high content of branched-chain amino acids (BCAAs). Inclusion of BCAAs in HF diets is known to
attenuate obesity in mice (leucine) [10] and rats [40], and chronic elevated levels of BCAAs in mice are
associated with increased energy expenditure [41].
We observed large differences in energy efficiency with an overall lower feed efficiency
demonstrated in mice fed diets based on casein. Energy may be dissipated to the environment
in the form of heat via UCP1, which uncouples oxidative phosphorylation in the inner mitochondrial
membrane present in brown and brown-like adipocytes [42], and increased expression and activity of
UCP1 protects against diet-induced obesity [43]. In line with the ability of casein intake to attenuate
obesity development [26], the classic brown adipose tissue morphology and high UCP1 expression
in iBAT were maintained after feeding lean mice a casein-based HF/HP diet. In already obese mice,
a “whitening” of the iBAT was evident. When combined with energy restriction, all mice receiving
HF/HP diets lost body and fat mass and the brown phenotype of iBAT was retrieved. However, the
white phenotype of iBAT was not reversed by feeding obese mice a casein-based HF/HP diet ad libitum,
and in line with this, only a modest reduction in body weight and fat mass was observed. This indicates
a greater potential for casein-derived HF/HP diets to prevent obesity and “whitening” of the iBAT,
than to reverse obesity and “whitening” of iBAT.
Compared with a pork-based HF/HP diet, the casein-based diet led to an increased expression
of brown adipocyte marker genes in white adipose tissue (WAT). Both obese and lean mice fed
the pork-based HF/HP diet had larger adipocytes in iWAT. Browning of WAT has been associated
with attenuated diet-induced obesity in several genetic models [43], and prevention of browning is
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demonstrated to impair fat loss induced by calorie restriction in mice [44]. However, it has been argued
that the quantitative contribution of the relatively low number of mitochondria in iWAT compared
with iBAT is minor [45]. Although further studies are required to determine the potential importance of
UCP1 in iBAT and/or iWAT, our results indicate that inclusion of casein in diets may prevent whitening
of iBAT and induce browning of iWAT.
Combined with calorie restriction, all HF/HP diets induced weight and fat mass loss independently
of the protein source. Similarly, we observed improved glucose tolerance and insulin sensitivity in
energy restricted mice, independently of protein source in HF/HP-fed mice. Hence, our study is not
in agreement with the assumption that the dietary fat content, rather than the obese state, may be a
key determinant for dysregulated glucose homeostasis [20–22]. Our results are in agreement with a
large human trial, demonstrating that a reduction in calorie intake induces weight loss independent of
the dietary macronutrient composition in obese adults [46]. When combined with caloric restriction,
all diets, including those with relatively HF content, improved lipid-related risk factors and fasting
insulin levels [46]. In our study, a LF diet in combination with calorie restriction was more efficient for
body weight and fat mass loss in mice when based on casein compared with cod and pork. This is
in agreement with a study in obese adults demonstrating that dairy products increased body weight
and fat mass loss induced by a standard energy restricted diet [47]. Hall et al. [48] demonstrated
dietary fat restriction to induce a higher body fat loss in obese adults compared with an isocaloric
diet restricted in carbohydrates, suggesting a LF diet to be more effective for weight loss compared
with a low carbohydrate diet. Our results from mice also demonstrate a greater fat mass loss during
the intake of LF diets compared with HF/HP diets. Furthermore, our results from calorie restricted
HF/HP-fed mice are in agreement with the recent finding that a HF intake (64E%) for 6 weeks does not
impair insulin sensitivity in healthy, slightly overweight men in caloric balance [49].
The protein sources used in this study were restricted to different animal-derived proteins, casein,
cod and pork, and thus we do not examine plant or insect proteins—protein sources of interest in
relation to more sustainable development. However, plant-based protein sources would also be of
interest to evaluate, as studies have demonstrated that the metabolic impact from plant-based proteins
differ from animal derived proteins [28,50]. Increasing the length of the experimental study could
potentially reveal additional effects between the different animal proteins used, especially the 6 week
intervention in the obese mice which may have been too short to induce significant metabolic alterations.
5. Conclusions
In already obese animals, the impact of the protein source on obesity varies depending on
energy intake and macronutrient composition, whereas glucose tolerance and insulin sensitivity in
general follow the differences detected in obesity development. Combined, our results demonstrate
that different animal protein sources may have a greater impact during obesity development than
during obesity reversal. Macronutrient composition and energy access modulate the impact of dietary
animal protein sources in obese mice. The dietary protein source significantly impacts the order of
magnitude for changes in body weight, fat mass, lean mass, feed efficiency, glucose tolerance and
insulin sensitivity in already obese animals fed HF/HP diets ad libitum or LF diets with or without
energy restriction. All the dietary interventions combined with calorie restriction from our study led to
a considerable body weight loss of obese mice, as in agreement with a number of human weight loss
interventions [46,51–56]. However, our study also demonstrated that the protein source appears to be
of no importance when combined with energy restriction and HF/HP intake, hence, the results indicate
that the dietary protein source is of greater importance in preventing weight gain than reversing obesity.
It may be considered whether dietary means for obesity prevention in lean persons should be different
from dietary advice given to obese subjects to achieve effective weight loss. On the basis of the high
number of adults and children currently being overweight or obese, the need for effective dietary
strategies to prevent, stabilize and reduce weight is urgent. Detecting differences in efficiency between
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dietary strategies and dietary sources for weight gain prevention and weight loss are of importance for
dietary recommendations.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/5/1153/
s1, Figure S1: (a) Hematoxylin and eosin (H&E) staining of inguinal white adipose tissue (iWAT) after 12
weeks of feeding ad libitum high-fat/high-protein (HF/HP) diets based on different protein sources to lean mice
(scalebar = 100µm). (b) Mean cell diameter ± SEM of adipocytes from iWAT (n = 4). (c) Expression levels of the
brown adipose tissue marker genes uncoupling protein 1 (Ucp1), deiodinase iodothyronine type II (Dio2) and
peroxisome proliferator-activated receptor-g coactivator 1a (Ppargc1a) in iWAT (n = 5–7). Expression levels are
normalized to the gene expression of TATA-box binding protein (Tbp). (d) H&E staining of interscapular brown
adipose tissue (iBAT) after 12 weeks of feeding ad libitum HF/HP diets based on different protein sources to lean
mice (scalebar = 100µm). (e) Immunohistochemical staining with UCP1-antibody and (f) quantification of percent
area stained with UCP1-antibody demonstrated as mean ± SEM (n = 3–5). Different letters denote significant
differences (P < 0.05) by one-way ANOVA using uncorrected Fisher’s LSD multiple comparison. Figure S2: (a)
Total energy intake (kcal) after 12 weeks, (b) apparent fat digestibility (%) and (c) apparent nitrogen digestibility
(%) after 6 weeks of feeding ad libitum high-fat/high-protein (HF/HP) diets based on different protein sources to
lean mice. Data are presented as mean ± SEM (n = 8–9) and different letters denote significant differences (P < 0.05)
by one way ANOVA using uncorrected Fisher’s LSD multiple comparison. Figure S3: (a) Hematoxylin and
eosin (H&E) staining of interscapular brown adipose tissue (iBAT) after 6 weeks of feeding high-fat/high-protein
(HF/HP) diets based on different protein sources ad libitum to already obese mice, in addition to one group fed
the obesogenic high fat high sucrose (HF/HS) diet for 6 weeks (scalebar = 100µm). (b) Immunohistochemical
staining with UCP1-antibody and (c) quantification of percent area stained with UCP1-antibody demonstrated as
mean ± SEM (n = 3–4). (d) HE staining of inguinal white adipose tissue (iWAT) (scalebar = 100µm). (e) Mean cell
diameter (± SEM) of adipocytes from iWAT (n = 4–5). Figure S4: Expression levels of brown adipose tissue marker
genes (uncoupling protein 1 (Ucp1), deiodinase iodothyronine type II (Dio2), peroxisome proliferator-activated
receptor-g coactivator 1a (Ppargc1a)) and leptin in (a) interscapular brown adipose tissue (iBAT) and (b) inguinal
white adipose tissue (iWAT) after 6 weeks of feeding highfat/high-protein (HF/HP) diets based on different protein
sources ad libitum or with 30 percent calorie restriction (CR) to already obese mice, in addition to one group fed the
obesogenic high-fat/high-sucrose (HF/HS) diet (n = 7–13). Expression levels are normalized to gene expression
of TATA-box binding protein (Tbp). Figure S5: Hematoxylin and eosin (H&E) staining of interscapular brown
adipose tissue (iBAT) after 6 weeks of feeding high-fat/high-protein (HF/HP) diets based on different protein
sources with 30 per cent calorie restriction (CR) to already obese mice, in addition to one group fed the obesogenic
high-fat/highsucrose (HF/HS) diet (scalebar = 100µm). Figure S6: Expression levels of brown adipose tissue marker
genes (uncoupling protein 1 (Ucp1), deiodinase iodothyronine type II (Dio2), peroxisome proliferator-activated
receptor-g coactivator 1a (Ppargc1a)), in addition to leptin and glycerol kinase (Gk) in (a) inguinal white adipose
tissue (iWAT) and (b) interscapular brown adipose tissue (iBAT) after 6 weeks of feeding low-fat (LF) diets based
on different protein sources ad libitum or with 30 percent calorie restriction (CR) to already obese mice, in addition
to one group fed the obesogenic very high-fat (VHF) diet ad libitum (n = 8–10). Expression levels are normalized to
gene expression of TATA-box binding protein (Tbp). Table S1: Primer sequences used for quantitative reverse
transcriptase PCR.
Author Contributions: Conceptualization: L.M., K.K., L.S.M. and E.F.; investigation: L.S.M., A.E.H., K.R.F., E.F.,
U.L., J.Ø. and A.B.; data curation and/or formal analysis: all authors; funding acquisition: K.K. and L.M.; writing—
original draft: L.S.M. and L.M.; writing—review and editing: all authors.
Funding: This research was funded by The Norwegian Seafood Research Fund, grant number FINS 900842 and
by the European Union FP7 project DIABAT (HEALTH-F2–2011–278373).
Acknowledgments: We thank the staff at IMR for technical assistance and in particular Aase Heltveit for
animal care.
Conflicts of Interest: The authors have no conflicting interests, financial or otherwise.
References
1. Hamman, R.F.; Wing, R.R.; Edelstein, S.L.; Lachin, J.M.; Bray, G.A.; Delahanty, L.; Hoskin, M.; Kriska, A.M.;
Mayer-Davis, E.J.; Pi-Sunyer, X.; et al. Effect of weight loss with lifestyle intervention on risk of diabetes.
Diabetes Care 2006, 29, 2102–2107. [CrossRef]
2. Koliaki, C.; Spinos, T.; Spinou, M.; Brinia Mu, E.; Mitsopoulou, D.; Katsilambros, N. Defining the Optimal
Dietary Approach for Safe, Effective and Sustainable Weight Loss in Overweight and Obese Adults. Healthcare
2018, 6, 73. [CrossRef]
3. Madsen, L.; Myrmel, L.S.; Fjære, E.; Øyen, J.; Kristiansen, K. Dietary Proteins, Brown Fat, and Adiposity.
Front. Physiol. 2018, 9, 1792. [CrossRef] [PubMed]
4. Pesta, D.H.; Samuel, V.T. A high-protein diet for reducing body fat: Mechanisms and possible caveats.
Nutr. Metab. 2014, 11, 53. [CrossRef] [PubMed]
Nutrients 2019, 11, 1153 17 of 19
5. Westerterp-Plantenga, M.S. Protein intake and energy balance. Regul. Pept. 2008, 149, 67–69. [CrossRef]
6. Cuenca-Sanchez, M.; Navas-Carrillo, D.; Orenes-Pinero, E. Controversies surrounding high-protein diet
intake: Satiating effect and kidney and bone health. Adv. Nutr. 2015, 6, 260–266. [CrossRef] [PubMed]
7. Lepe, M.; Bacardi Gascon, M.; Jimenez Cruz, A. Long-term efficacy of high-protein diets: A systematic
review. Nutr. Hosp. 2011, 26, 1256–1259. [CrossRef] [PubMed]
8. Santesso, N.; Akl, E.A.; Bianchi, M.; Mente, A.; Mustafa, R.; Heels-Ansdell, D.; Schunemann, H.J. Effects
of higher- versus lower-protein diets on health outcomes: A systematic review and meta-analysis. Eur. J.
Clin. Nutr. 2012, 66, 780–788. [CrossRef] [PubMed]
9. Wycherley, T.P.; Moran, L.J.; Clifton, P.M.; Noakes, M.; Brinkworth, G.D. Effects of energy-restricted
high-protein, low-fat compared with standard-protein, low-fat diets: A meta-analysis of randomized
controlled trials. Am. J. Clin. Nutr. 2012, 96, 1281–1298. [CrossRef]
10. Freudenberg, A.; Petzke, K.J.; Klaus, S. Comparison of high-protein diets and leucine supplementation in
the prevention of metabolic syndrome and related disorders in mice. J. Nutr. Biochem. 2012, 23, 1524–1530.
[CrossRef]
11. Freudenberg, A.; Petzke, K.J.; Klaus, S. Dietary L-leucine and L-alanine supplementation have similar acute
effects in the prevention of high-fat diet-induced obesity. Amino Acids 2013, 44, 519–528. [CrossRef]
12. Hao, Q.; Lillefosse, H.H.; Fjaere, E.; Myrmel, L.S.; Midtbo, L.K.; Jarlsby, R.H.; Ma, T.; Jia, B.; Petersen, R.K.;
Sonne, S.B.; et al. High-glycemic index carbohydrates abrogate the antiobesity effect of fish oil in mice. Am. J.
Physiol. Endocrinol. Metab. 2012, 302, E1097–E1112. [CrossRef]
13. Kiilerich, P.; Myrmel, L.S.; Fjaere, E.; Hao, Q.; Hugenholtz, F.; Sonne, S.B.; Derrien, M.; Pedersen, L.M.;
Petersen, R.K.; Mortensen, A.; et al. Effect of a long-term high-protein diet on survival, obesity development,
and gut microbiota in mice. Am. J. Physiol. Endocrinol. Metab. 2016, 310, E886–E899. [CrossRef]
14. Ma, T.; Liaset, B.; Hao, Q.; Petersen, R.K.; Fjaere, E.; Ngo, H.T.; Lillefosse, H.H.; Ringholm, S.; Sonne, S.B.;
Treebak, J.T.; et al. Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases
obesity development in mice. PLoS ONE 2011, 6, e21647. [CrossRef] [PubMed]
15. Madsen, L.; Pedersen, L.M.; Liaset, B.; Ma, T.; Petersen, R.K.; van den Berg, S.; Pan, J.; Muller-Decker, K.;
Dulsner, E.D.; Kleemann, R.; et al. cAMP-dependent signaling regulates the adipogenic effect of n-6
polyunsaturated fatty acids. J. Biol. Chem. 2008, 283, 7196–7205. [CrossRef] [PubMed]
16. Marsset-Baglieri, A.; Fromentin, G.; Tome, D.; Bensaid, A.; Makkarios, L.; Even, P.C. Increasing the protein
content in a carbohydrate-free diet enhances fat loss during 35% but not 75% energy restriction in rats. J. Nutr.
2004, 134, 2646–2652. [CrossRef] [PubMed]
17. McAllan, L.; Skuse, P.; Cotter, P.D.; O’Connor, P.; Cryan, J.F.; Ross, R.P.; Fitzgerald, G.; Roche, H.M.;
Nilaweera, K.N. Protein quality and the protein to carbohydrate ratio within a high fat diet influences energy
balance and the gut microbiota in C57BL/6J mice. PLoS ONE 2014, 9, e88904. [CrossRef]
18. Morens, C.; Keijzer, M.; de Vries, K.; Scheurink, A.; van Dijk, G. Effects of high-fat diets with different
carbohydrate-to-protein ratios on energy homeostasis in rats with impaired brain melanocortin receptor
activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R156–R163. [CrossRef] [PubMed]
19. Pichon, L.; Huneau, J.F.; Fromentin, G.; Tome, D. A high-protein, high-fat, carbohydrate-free diet reduces
energy intake, hepatic lipogenesis, and adiposity in rats. J. Nutr. 2006, 136, 1256–1260. [CrossRef] [PubMed]
20. Fjaere, E.; Aune, U.L.; Roen, K.; Keenan, A.H.; Ma, T.; Borkowski, K.; Kristensen, D.M.; Novotny, G.W.;
Mandrup-Poulsen, T.; Hudson, B.D.; et al. Indomethacin Treatment Prevents High Fat Diet-induced Obesity
and Insulin Resistance but Not Glucose Intolerance in C57BL/6J Mice. J. Biol. Chem. 2014, 289, 16032–16045.
[CrossRef] [PubMed]
21. Harris, R.B.; Kor, H. Insulin insensitivity is rapidly reversed in rats by reducing dietary fat from 40 to 30% of
energy. J. Nutr. 1992, 122, 1811–1822. [CrossRef] [PubMed]
22. Jensen, B.A.H.; Nielsen, T.S.; Fritzen, A.M.; Holm, J.B.; Fjære, E.; Serup, A.K.; Borkowski, K.; Risis, S.;
Pærregaard, S.I.; Søgaard, I.; et al. Dietary fat drives whole-body insulin resistance and promotes intestinal
inflammation independent of body weight gain. Metab. Clin. Exp. 2016, 65, 1706–1719. [CrossRef]
23. Gao, X.; Yan, D.; Zhao, Y.; Tao, H.; Zhou, Y. Moderate calorie restriction to achieve normal weight reverses
β-cell dysfunction in diet-induced obese mice: Involvement of autophagy. Nutr. Metab. 2015, 12, 34.
[CrossRef]
Nutrients 2019, 11, 1153 18 of 19
24. Fjaere, E.; Myrmel, L.S.; Lutzhoft, D.O.; Andersen, H.; Holm, J.B.; Kiilerich, P.; Hannisdal, R.; Liaset, B.;
Kristiansen, K.; Madsen, L. Effects of exercise and dietary protein sources on adiposity and insulin sensitivity
in obese mice. J. Nutr. Biochem. 2019, 66, 98–109. [CrossRef]
25. Wang, N.; Liu, Y.; Ma, Y.; Wen, D. High-intensity interval versus moderate-intensity continuous training:
Superior metabolic benefits in diet-induced obesity mice. Life Sci. 2017, 191, 122–131. [CrossRef]
26. Liisberg, U.; Myrmel, L.S.; Fjaere, E.; Ronnevik, A.K.; Bjelland, S.; Fauske, K.R.; Holm, J.B.; Basse, A.L.;
Hansen, J.B.; Liaset, B.; et al. The protein source determines the potential of high protein diets to attenuate
obesity development in C57BL/6J mice. Adipocyte 2016, 5, 196–211. [CrossRef] [PubMed]
27. Mozaffarian, D.; Hao, T.; Rimm, E.B.; Willett, W.C.; Hu, F.B. Changes in diet and lifestyle and long-term
weight gain in women and men. N. Engl. J. Med. 2011, 364, 2392–2404. [CrossRef]
28. Smith, J.D.; Hou, T.; Ludwig, D.S.; Rimm, E.B.; Willett, W.; Hu, F.B.; Mozaffarian, D. Changes in intake of
protein foods, carbohydrate amount and quality, and long-term weight change: Results from 3 prospective
cohorts. Am. J. Clin. Nutr. 2015, 101, 1216–1224. [CrossRef]
29. Tastesen, H.S.; Keenan, A.H.; Madsen, L.; Kristiansen, K.; Liaset, B. Scallop protein with endogenous high
taurine and glycine content prevents high-fat, high-sucrose-induced obesity and improves plasma lipid
profile in male C57BL/6J mice. Amino Acids 2014, 46, 1659–1671. [CrossRef] [PubMed]
30. Fauske, K.R.; Bernhard, A.; Fjaere, E.; Myrmel, L.S.; Froyland, L.; Kristiansen, K.; Liaset, B.; Madsen, L.
Effects of Frozen Storage on Phospholipid Content in Atlantic Cod Fillets and the Influence on Diet-Induced
Obesity in Mice. Nutrients 2018, 10, 695. [CrossRef]
31. Halldorsdottir, S.; Carmody, J.; Boozer, C.N.; Leduc, C.A.; Leibel, R.L. Reproducibility and accuracy of body
composition assessments in mice by dual energy X-ray absorptiometry and time domain nuclear magnetic
resonance. Int. J. Body Compos. Res. 2009, 7, 147–154.
32. Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch, T.; Preibisch, S.; Rueden, C.;
Saalfeld, S.; Schmid, B.; et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 2012,
9, 676–682. [CrossRef]
33. Lillefosse, H.H.; Tastesen, H.S.; Du, Z.Y.; Ditlev, D.B.; Thorsen, F.A.; Madsen, L.; Kristiansen, K.; Liaset, B.
Hydrolyzed Casein Reduces Diet-Induced Obesity in Male C57BL/6J Mice. J. Nutr. 2013, 143, 1367–1375.
[CrossRef]
34. Lasar, D.; Rosenwald, M.; Kiehlmann, E.; Balaz, M.; Tall, B.; Opitz, L.; Lidell, M.E.; Zamboni, N.; Krznar, P.;
Sun, W.; et al. Peroxisome Proliferator Activated Receptor Gamma Controls Mature Brown Adipocyte
Inducibility through Glycerol Kinase. Cell Rep. 2018, 22, 760–773. [CrossRef] [PubMed]
35. Holm, J.B.; Ronnevik, A.; Tastesen, H.S.; Fjaere, E.; Fauske, K.R.; Liisberg, U.; Madsen, L.; Kristiansen, K.;
Liaset, B. Diet-induced obesity, energy metabolism and gut microbiota in C57BL/6J mice fed Western diets
based on lean seafood or lean meat mixtures. J. Nutr. Biochem. 2016, 31, 127–136. [CrossRef] [PubMed]
36. Tastesen, H.S.; Ronnevik, A.K.; Borkowski, K.; Madsen, L.; Kristiansen, K.; Liaset, B. A mixture of cod
and scallop protein reduces adiposity and improves glucose tolerance in high-fat fed male C57BL/6J mice.
PLoS ONE 2014, 9, e112859. [CrossRef] [PubMed]
37. Liisberg, U.; Fauske, K.R.; Kuda, O.; Fjaere, E.; Myrmel, L.S.; Norberg, N.; Froyland, L.; Graff, I.E.; Liaset, B.;
Kristiansen, K.; et al. Intake of a Western diet containing cod instead of pork alters fatty acid composition in
tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice. J. Nutr. Biochem. 2016,
33, 119–127. [CrossRef]
38. Fogelholm, M.; Anderssen, S.; Gunnarsdottir, I.; Lahti-Koski, M. Dietary macronutrients and food
consumption as determinants of long-term weight change in adult populations: A systematic literature
review. Food Nutr. Res. 2012, 56, 19103. [CrossRef] [PubMed]
39. Thorning, T.K.; Raben, A.; Tholstrup, T.; Soedamah-Muthu, S.S.; Givens, I.; Astrup, A. Milk and dairy
products: Good or bad for human health? An assessment of the totality of scientific evidence. Food Nutr. Res.
2016, 60, 32527. [CrossRef]
40. Newgard, C.B.; An, J.; Bain, J.R.; Muehlbauer, M.J.; Stevens, R.D.; Lien, L.F.; Haqq, A.M.; Shah, S.H.;
Arlotto, M.; Slentz, C.A.; et al. A branched-chain amino acid-related metabolic signature that differentiates
obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9, 311–326. [CrossRef]
[PubMed]
Nutrients 2019, 11, 1153 19 of 19
41. She, P.; Reid, T.M.; Bronson, S.K.; Vary, T.C.; Hajnal, A.; Lynch, C.J.; Hutson, S.M. Disruption of BCATm in
mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle.
Cell Metab. 2007, 6, 181–194. [CrossRef] [PubMed]
42. Cannon, B.; Nedergaard, J. Brown adipose tissue: Function and physiological significance. Physiol. Rev. 2004,
84, 277–359. [CrossRef]
43. Harms, M.; Seale, P. Brown and beige fat: Development, function and therapeutic potential. Nat. Med. 2013,
19, 1252–1263. [CrossRef]
44. Fabbiano, S.; Suarez-Zamorano, N.; Rigo, D.; Veyrat-Durebex, C.; Stevanovic Dokic, A.; Colin, D.J.;
Trajkovski, M. Caloric Restriction Leads to Browning of White Adipose Tissue through Type 2 Immune
Signaling. Cell Metab. 2016, 24, 434–446. [CrossRef]
45. Shabalina, I.G.; Petrovic, N.; de Jong, J.M.; Kalinovich, A.V.; Cannon, B.; Nedergaard, J. UCP1 in brite/beige
adipose tissue mitochondria is functionally thermogenic. Cell Rep. 2013, 5, 1196–1203. [CrossRef] [PubMed]
46. Sacks, F.M.; Bray, G.A.; Carey, V.J.; Smith, S.R.; Ryan, D.H.; Anton, S.D.; McManus, K.; Champagne, C.M.;
Bishop, L.M.; Laranjo, N.; et al. Comparison of weight-loss diets with different compositions of fat, protein,
and carbohydrates. N. Engl. J. Med. 2009, 360, 859–873. [CrossRef] [PubMed]
47. Zemel, M.B.; Thompson, W.; Milstead, A.; Morris, K.; Campbell, P. Calcium and dairy acceleration of weight
and fat loss during energy restriction in obese adults. Obes. Res. 2004, 12, 582–590. [CrossRef]
48. Hall, K.D.; Bemis, T.; Brychta, R.; Chen, K.Y.; Courville, A.; Crayner, E.J.; Goodwin, S.; Guo, J.; Howard, L.;
Knuth, N.D.; et al. Calorie for Calorie, Dietary Fat Restriction Results in More Body Fat Loss than
Carbohydrate Restriction in People with Obesity. Cell Metab. 2015, 22, 427–436. [CrossRef]
49. Lundsgaard, A.M.; Holm, J.B.; Sjoberg, K.A.; Bojsen-Moller, K.N.; Myrmel, L.S.; Fjaere, E.; Jensen, B.A.H.;
Nicolaisen, T.S.; Hingst, J.R.; Hansen, S.L.; et al. Mechanisms Preserving Insulin Action during High Dietary
Fat Intake. Cell Metab. 2019, 29, 50–63. [CrossRef]
50. Levine, M.E.; Suarez, J.A.; Brandhorst, S.; Balasubramanian, P.; Cheng, C.-W.; Madia, F.; Fontana, L.;
Mirisola, M.G.; Guevara-Aguirre, J.; Wan, J.; et al. Low protein intake is associated with a major reduction
in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014,
19, 407–417. [CrossRef]
51. Layman, D.K.; Evans, E.M.; Erickson, D.; Seyler, J.; Weber, J.; Bagshaw, D.; Griel, A.; Psota, T.; Kris-Etherton, P.
A moderate-protein diet produces sustained weight loss and long-term changes in body composition and
blood lipids in obese adults. J. Nutr. 2009, 139, 514–521. [CrossRef] [PubMed]
52. Melanson, K.; Gootman, J.; Myrdal, A.; Kline, G.; Rippe, J.M. Weight loss and total lipid profile changes in
overweight women consuming beef or chicken as the primary protein source. Nutrition 2003, 19, 409–414.
[CrossRef]
53. Mori, T.A.; Bao, D.Q.; Burke, V.; Puddey, I.B.; Watts, G.F.; Beilin, L.J. Dietary fish as a major component of
a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive
subjects. Am. J. Clin. Nutr. 1999, 70, 817–825. [CrossRef] [PubMed]
54. Thorsdottir, I.; Tomasson, H.; Gunnarsdottir, I.; Gisladottir, E.; Kiely, M.; Parra, M.D.; Bandarra, N.M.;
Schaafsma, G.; Martinez, J.A. Randomized trial of weight-loss-diets for young adults varying in fish and fish
oil content. In.t J. Obes. 2007, 31, 1560–1566. [CrossRef]
55. Wycherley, T.P.; Brinkworth, G.D.; Clifton, P.M.; Noakes, M. Comparison of the effects of 52 weeks weight
loss with either a high-protein or high-carbohydrate diet on body composition and cardiometabolic risk
factors in overweight and obese males. Nutr. Diabetes 2012, 2, e40. [CrossRef] [PubMed]
56. Yamashita, T.; Sasahara, T.; Pomeroy, S.E.; Collier, G.; Nestel, P.J. Arterial compliance, blood pressure, plasma
leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and
a plant-based diet. Metab. Clin. Exp. 1998, 47, 1308–1314. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
